Home Institutional

Institutional

Vyleesi (bremelanotide) has been approved to treat acquired

Vyleesi Approved for Hypoactive Sexual Desire Disorder in Women

HealthDay.com -
0
The U.S. National Domestic Violence Hotline had its busiest year ever in 2018

2018 Busiest Year Ever for U.S. National Domestic Violence Hotline

HealthDay.com -
0
The indication for a cystic fibrosis treatment

FDA Expands Cystic Fibrosis Treatment Approval to Children Ages 6 to...

HealthDay.com -
0
More Americans age 55 years and older are undergoing cosmetic procedures

2018 Saw Increase in Cosmetic Procedures for Over 55s

HealthDay.com -
0
From 1999 to 2017

Suicide Rates Increased for Men, Women From 1999 to 2017

HealthDay.com -
0
The new editor-in-chief of the prestigious New England Journal of Medicine is Eric J. Rubin

New England Journal of Medicine Picks New Editor-in-Chief

HealthDay.com -
0
A ban on the sale and distribution of electronic cigarettes is being considered by San Francisco supervisors. If passed

San Francisco Considering Banning Sales of E-Cigarettes

HealthDay.com -
0
Victoza (liraglutide) injection is now approved to treat type 2 diabetes in children 10 years and older

FDA Approves Victoza Injection for Children 10 Years and Older

HealthDay.com -
0
Even though the Ebola outbreak in Congo recently caused deaths in neighboring Uganda

WHO: Congo Ebola Outbreak Still Not Global Emergency

HealthDay.com -
0
Three large drug makers have launched a legal challenge against the Trump administration's rule requiring the prices of drugs to be included in television ads.

Drug Makers Challenge New Rule Requiring Drug Prices in TV Ads

HealthDay.com -
0
123...138Page 1 of 138

EVEN MORE NEWS

POPULAR CATEGORY

© 2016 eHealthcare Solutions, LLC
810 Bear Tavern Road, Suite 102, Ewing, NJ 08628
Ph: (609) 882-8887 | Fx: (425) 671-7796